Elutia Inc.’s (NASDAQ:ELUT) Price Is Right But Growth Is Lacking After Shares Rocket 27%
Elutia Inc. (NASDAQ:ELUT) shareholders have had their patience rewarded with a 27% share price jump in the last month. Unfortunately, the gains of the last month did little to right the losses of the last year with the stock still down 43% over that time.
Even after such a large jump in price, Elutia’s price-to-sales (or “P/S”) ratio of 4.2x might still make it look like a strong buy right now compared to the wider Biotechs industry in the United States, where around half of the companies have P/S ratios above 8.9x and even P/S above 65x are quite common. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s so limited.
AI is about to change healthcare. These 20 stocks are working…
